Skip to Main Content

Paper Details

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.
Science
91
2021
CD163, CD163+PD-L1- myeloid cells, CD8, CD8+FoxP3+PD-1low/, FoxP3, PD-1, PD-1low, PD-L1, PD-L1- myeloid cells, melanoma, mid T cells, patients, tissue, tumor
Author NameAffiliation
Joel C SunshineJohns Hopkins University School of Medicine
Elizabeth M JaffeeThe Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University
Elizabeth M JaffeeBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Elizabeth M JaffeeJohns Hopkins University School of Medicine
Harriet M KlugerYale University School of Medicine
Harriet M KlugerYale University School of Medicine
Leslie CopeThe Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University
Leslie CopeBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Leslie CopeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Ludmila DanilovaThe Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Ludmila DanilovaBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Ludmila DanilovaThe Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University
Ludmila DanilovaBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
David L RimmYale University School of Medicine
  • 1 - 16

Datasets

Release 1.2